Stratview Research has published a new report titled “Glucose Monitoring System Market” which is segmented By Type (Sensors, Transmitters Receivers, Integrated Insulin Pumps), End-User (Hospitals, Clinics, Home Healthcare), and Region.
As per the study, The Glucose Monitoring System market is projected to grow from USD 2.02 billion in 2021 to USD 3.06 billion by 2028 at a CAGR of around 6.19% during the forecast period of 2022-2028.
Report Highlights
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides thorough analysis of the market segments which include products, applications, and competitor analysis.
The market is bifurcated into various segments. Below given is the segment-wise analysis -
By end-user, the glucose monitoring system market has been bifurcated into hospitals, clinics, and home healthcare. Under these, the hospitals' segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure, technical expertise, and professional healthcare staff.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to expanding geriatric populace and rising incidences of diabetes coupled with the presence of key market players such as Echo Therapeutics Inc. (US) and Insulet Corporation (US). The market growth in the Asia-Pacific region is expected to be driven by the increasing number of people having diabetes due to a sedentary lifestyle in developing countries, particularly China and India.
Who are the Key Players in the Market?
This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, that will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players activen in the Glucose Monitoring System Market:
- Medtronic plc (Ireland)
- Abbott Laboratories (US)
- DexCom, Inc. (US)
- Echo Therapeutics Inc. (US)
- Insulet Corporation (US)
- Johnson Johnson (US)
- Senseonics Holdings, Inc. (US)
- Hoffmann-La Roche AG (Switzerland)
- AgaMatrix Inc. (Germany)
- Glysure Ltd (UK)
- ORSENSE LTD (Israel)
- Ypsomed (Switzerland)
Request a sample here- https://www.stratviewresearch.com/Request-Sample/2390/Glucose-Monitoring-System-Market.html#form
Custom Research:
Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to [email protected]. Or connect with our experts at +1-313-307-4176.
About Us
Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.
